Who Should Take Paxlovid 2025. The same problem exists with antivirals for influenza. The decision to prescribe someone paxlovid for a covid infection should be made based on a patient’s risk factors for severe disease, regardless of symptom severity.
The same problem exists with antivirals for influenza. In such groups, nirmatrelvir/ritonavir (paxlovid) demonstrated high efficacy against severe outcomes (hammond, february 2022).